During the last session, Veracyte Inc (NASDAQ:VCYT)’s traded shares were 1.55 million, with the beta value of the company hitting 2.01. At the end of the trading day, the stock’s price was $32.96, reflecting an intraday loss of -3.37% or -$1.15. The 52-week high for the VCYT share is $47.32, that puts it down -43.57 from that peak though still a striking 43.54% gain since the share price plummeted to a 52-week low of $18.61. The company’s market capitalization is $2.57B, and the average trade volume was 843.04K shares over the past three months.
Veracyte Inc (NASDAQ:VCYT) trade information
Veracyte Inc (VCYT) registered a -3.37% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -3.37% in intraday trading to $32.96, hitting a weekly high. The stock’s 5-day price performance is -7.23%, and it has moved by -26.85% in 30 days. Based on these gigs, the overall price performance for the year is 37.33%.
The consensus price target of analysts on Wall Street is $44, which implies an increase of 25.09% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $44 and $44 respectively. As a result, VCYT is trading at a discount of -33.5% off the target high and -33.5% off the low.
Veracyte Inc (VCYT) estimates and forecasts
In the rating firms’ projections, revenue will increase 9.37% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 110.6M as predicted by 9 analyst(s). Meanwhile, a consensus of 9 analyst(s) estimates revenue growth to 121.77M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 96.84M and 114.43M respectively. In this case, analysts expect current quarter sales to grow by 14.20% and then jump by 6.42% in the coming quarter.
While earnings are projected to return 59.68% in 2025, the next five years will return 53.44% per annum.
VCYT Dividends
Veracyte Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 7.5 million shares, is of VANGUARD GROUP INC’s that is approximately 10.0281% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $162.46 million.
Also, the Mutual Funds coming in first place with the largest holdings of Veracyte Inc (VCYT) shares are Vanguard Explorer Fund, Inc. and ARK ETF Tr-ARK Innovation ETF . Data provided on Oct 31, 2024 indicates that Vanguard Explorer Fund, Inc. owns about 2.8 shares. This amounts to just over 3.59 percent of the company’s overall shares, with a $92.29 million market value. The same data shows that the other fund manager holds slightly less at 2.68, or about 3.44% of the stock, which is worth about $88.48 million.
